Stay updated on Nivolumab in Resectable Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable Osteosarcoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Introduced a consolidated Locations section listing participating states (Alabama, California, Colorado, Connecticut, Delaware, Florida, Kentucky, Maryland, New York, North Carolina, Ohio, Tennessee, Texas) and updated the page to revision v3.3.3, replacing the previous state-specific location blocks.
    Difference
    1%
    Check dated 2025-12-23T17:13:16.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.2 in the page footer.
    Difference
    0.0%
    Check dated 2025-11-24T21:55:19.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added institutional names and related footer links: Moffitt Cancer Center Clinical Trials website; H. Lee Moffitt Cancer Center and Research Institute; Helpful Links Provided by. Removed a government funding status notice that previously appeared on the page.
    Difference
    0.5%
    Check dated 2025-11-17T20:04:24.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added recent update timestamps to the Study Record Dates (2025-10-31, 2025-10-30, 2025-10) and removed older August timestamps (2025-08-05, 2025-08-04, 2025-08). These changes do not alter the study content, eligibility criteria, or outcomes.
    Difference
    0.5%
    Check dated 2025-11-03T13:48:09.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    - Added a government funding notice about potential delays and current operating status, plus a link to opm.gov for updates. - Added new Genetic and Rare Diseases Information Center resource: Bone osteosarcoma. - Version revision updated from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T04:15:34.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:35:59.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.